PatientsVille.com Logo

PatientsVille

Mononessa Side Effects

Common Mononessa Side Effects


The most commonly reported Mononessa side effects (click to view or check a box to report):

Deep Vein Thrombosis (9)
Patella Fracture (6)
Irritability (4)
Pneumonia (4)
Depression (4)
Thrombosis (3)
Embolism (2)
Pelvic Pain (2)
Abortion Spontaneous (2)
Menometrorrhagia (2)
Phlebitis (2)
Heart Rate Increased (2)
Headache (2)
Pulmonary Embolism (2)
Polymenorrhoea (2)
Pleural Effusion (2)
Pregnancy On Oral Contraceptive (2)
Rhinitis Allergic (2)
Sleep Disorder (2)
Superior Vena Cava Syndrome (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Mononessa Side Effects Reported to FDA

The following Mononessa reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Mononessa on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Pulmonary Embolism, Deep Vein Thrombosis
This is a report of a 30-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: contraception, who was treated with Mononessa (dosage: 1??chronic, start time: NS), combined with:
  • Topiramate
  • Levothyroxine
and developed a serious reaction and side effect(s). The consumer presented with:
  • Pulmonary Embolism
  • Deep Vein Thrombosis
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Mononessa treatment in female patients, resulting in pulmonary embolism side effect. The patient was hospitalized.

Deep Vein Thrombosis, Musculoskeletal Stiffness
This report suggests a potential Mononessa Deep Vein Thrombosis, Musculoskeletal Stiffness side effect(s) that can have serious consequences. A 23-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: ovarian cyst and used Mononessa (dosage: NA) starting Oct 08, 2013. Soon after starting Mononessa the patient began experiencing various side effects, including:
  • Deep Vein Thrombosis
  • Musculoskeletal Stiffness
Drugs used concurrently: NA. Although Mononessa demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as deep vein thrombosis, may still occur.

Haemoptysis, Haematochezia, Off Label Use
This Haemoptysis, Haematochezia, Off Label Use problem was reported by a consumer or non-health professional from US. A 13-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: ovarian cyst. On 201208 this consumer started treatment with Mononessa (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Mononessa, the patient experienced the following unwanted symptoms/side effects:
  • Haemoptysis
  • Haematochezia
  • Off Label Use
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as haemoptysis, may become evident only after a product is in use by the general population.

Superior Vena Cava Syndrome, Embolism
This is a report of a 24-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: NA and was treated with Mononessa (dosage: Unk) starting May 28, 2010. Concurrently used drugs:
  • Etoposide (Unk)
  • Dexamethasone (Unk)
  • Prednisone (600 Milligram)
  • Sprycel (Unk)
  • Hydrocortisone (Unk)
  • Ifosfamide (Unk)
  • Cyclophosphamide (Unk)
  • Cytarabine (Unk)
Soon after that, the consumer experienced the following side effects:
  • Superior Vena Cava Syndrome
  • Embolism
The patient was hospitalized. This opens a possibility that Mononessa treatment could cause the above reactions, including superior vena cava syndrome, and some female subjects may be more susceptible.


Superior Vena Cava Syndrome, Embolism
A 24-year-old female patient (weight: NA) from US with the following symptoms/conditions: NA started Mononessa treatment (dosage: NA) on May 28, 2010. Soon after starting Mononessa treatment, the subject experienced various side effects, including:
  • Superior Vena Cava Syndrome
  • Embolism
Concurrently used drugs:
  • Dasatinib (Total 15 Courses And Total Dose 2100 Mg Received)
  • Dasatinib
  • Etoposide
  • Hydrocortisone
  • Ifosfamide
  • Cyclophosphamide
  • Cytarabine
  • Daunorubicin
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Mononessa.

Menstruation Irregular
A female patient from UNITED STATES (weight: NA) experienced symptoms, such as: contraception,post coital contraception and was treated with Mononessa(dosage: NA). The treatment was initiated on Apr 13, 2012. After that a consumer reported the following side effect(s):
  • Menstruation Irregular
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Mononessa efficacy:
  • Plan B One-step (1.5 Milligram;)


Emotional Distress, Anhedonia, Pain, Anxiety, Deep Vein Thrombosis
In this report, Mononessa-28 was administered for the following condition: NA.A 29-year-old female consumer from UNITED STATES (weight: NA) started Mononessa-28 treatment (dosage: NA) on Jan 01, 2009.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Emotional Distress
  • Anhedonia
  • Pain
  • Anxiety
  • Deep Vein Thrombosis
A possible interaction with other drugs could have contributed to this reaction:
  • Vitamin C (Unk)
  • Albuterol Inhaler (Unk)
  • Ibuprofen (Unk Unk, Prn)
  • Yaz (Unk)
  • Yaz
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Mononessa-28 treatment could be related to the listed above side effect(s).

Palpitations, Blood Pressure Systolic Increased, Heart Rate Increased, Body Temperature Increased
This is a report of the following Mononessa side effect(s):
  • Palpitations
  • Blood Pressure Systolic Increased
  • Heart Rate Increased
  • Body Temperature Increased
A 24-year-old female patient from UNITED STATES (weight: NA) presented with the following condition: acne and received a treatment with Mononessa (dosage: 1 Pill) starting: NS.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Mononessa treatment could be associated with the listed above side effect(s).

Gallbladder Injury, Hepatomegaly, Liver Disorder, Appendicitis, Biliary Dyskinesia, Hepatic Steatosis, Gastrointestinal Injury, Pancreatitis
This Mononessa-28 report was submitted by a 20-year-old female consumer from UNITED STATES (weight: NA). The patient was diagnosed with: NA and Mononessa-28 was administered (dosage: NA) starting: Jan 01, 2008. The consumer developed a set of symptoms:
  • Gallbladder Injury
  • Hepatomegaly
  • Liver Disorder
  • Appendicitis
  • Biliary Dyskinesia
  • Hepatic Steatosis
  • Gastrointestinal Injury
  • Pancreatitis
Other drugs used simultaneously:
  • Synthroid (125 Mgc)
  • Xanax (Unk, Qid)
  • Depakote (500 Mg, Unk)
  • Percocet (Unk, Qid)
  • Yasmin
  • Omeprazole (20 Mg, Unk)
  • Compazine
  • Percocet (5/325 Mg, Q4hr)
The patient was hospitalized.Those unexpected symptoms could be linked to a Mononessa-28 treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Thrombosis, Deep Vein Thrombosis
This is a report of a possible correlation between Mononessa use and the following symptoms/side effect(s):
  • Thrombosis
  • Deep Vein Thrombosis
which could contribute to an assessment of Mononessa risk profile.A female consumer from UNITED STATES (weight: NA) was suffering from contraception and was treated with Mononessa (dosage: Ethinyl Estradiol 0.035 Mg/norgestimate 0.25 Mg) starting NS.Other concurrent medications: NA.

Abortion Spontaneous, Pregnancy On Oral Contraceptive, Ovarian Cyst, Exposure During Pregnancy, Pelvic Pain, Polymenorrhoea, Menometrorrhagia
A 23-year-old female patient from US (weight: NA) presented with the following symptoms: contraception and after a treatment with Mononessa (dosage: NA) experienced the following side effect(s):
  • Abortion Spontaneous
  • Pregnancy On Oral Contraceptive
  • Ovarian Cyst
  • Exposure During Pregnancy
  • Pelvic Pain
  • Polymenorrhoea
  • Menometrorrhagia
The treatment was started on NS. Mononessa was used in combination with the following drugs: NA.This report could alert potential Mononessa consumers.

Pulmonary Embolism
In this report, a 22-year-old female patient from UNITED STATES (weight: NA) was affected by a possible Mononessa 35mcg/0.25mg side effect.The patient was diagnosed with oral contraception. After a treatment with Mononessa 35mcg/0.25mg (dosage: 1 Tablet Daily Po, start date: Dec 03, 2010), the patient experienced the following side effect(s):
  • Pulmonary Embolism
The following simultaneously used drugs could have led to this reaction: NA.The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Mononessa 35mcg/0.25mg treatment.

Panic Attack
This is a report of a 21-year-old female patient from UNITED STATES (weight: NA), who used Mononessa 0.250 Mg Norgestimate Jollc/watson (dosage: 1 Pill Once A Day Po) for a treatment of contraception. After starting a treatment on NS, the patient experienced the following side effect(s):
  • Panic Attack
The following drugs could possibly have interacted with the Mononessa 0.250 Mg Norgestimate Jollc/watson treatment
  • Mononessa 0,035 Mg Ethinyl Estradiol Jollc/watson (1 Pill Once A Day Po)
Taken together, these observations suggest that a Mononessa 0.250 Mg Norgestimate Jollc/watson treatment could be related to side effect(s), such as Panic Attack.

Abortion Spontaneous, Menometrorrhagia, Ovarian Cyst, Pelvic Pain, Polymenorrhoea, Pregnancy On Oral Contraceptive
This abortion spontaneous side effect was reported by a consumer or non-health professional from UNITED STATES. A 23-year-old female patient (weight:NA) experienced the following symptoms/conditions: contraception. The patient was prescribed Mononessa (dosage: NA), which was started on NS. Concurrently used drugs: NA. When starting to take Mononessa the consumer reported the following symptoms:
  • Abortion Spontaneous
  • Menometrorrhagia
  • Ovarian Cyst
  • Pelvic Pain
  • Polymenorrhoea
  • Pregnancy On Oral Contraceptive
These side effects may potentially be related to Mononessa.

Metrorrhagia, Mood Swings, Uterine Spasm
This is a Mononessa side effect report of a 21-year-old female patient (weight:NA) from UNITED STATES, suffering from the following symptoms/conditions: NA, who was treated with Mononessa (dosage:NA, start time: NS), combined with: NA., and developed a serious reaction and a metrorrhagia side effect. The patient presented with:
  • Metrorrhagia
  • Mood Swings
  • Uterine Spasm
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Mononessa treatment in female patients suffering from NA, resulting in metrorrhagia.

Deep Vein Thrombosis, Depression, Irritability, Patella Fracture, Pleural Effusion, Pneumonia, Rhinitis Allergic, Sleep Disorder, Vaginal Discharge
This report suggests a potential Mononessa deep vein thrombosis side effect(s) that can have serious consequences. A female patient from UNITED STATES (weight:NA) was diagnosed with the following health condition(s): contraception and used Mononessa (dosage: Ethinyl Estradiol 0.035mg/ Norgestimate 0.25 Mg) starting NS. Soon after starting Mononessa the patient began experiencing various side effects, including:
  • Deep Vein Thrombosis
  • Depression
  • Irritability
  • Patella Fracture
  • Pleural Effusion
  • Pneumonia
  • Rhinitis Allergic
  • Sleep Disorder
  • Vaginal Discharge
Drugs used concurrently:NA. The patient was hospitalized. Although Mononessa demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as deep vein thrombosis, may still occur.

Depression, Dizziness, Emotional Disorder, Fatigue, Feeling Abnormal, Headache, Irritability, Pain In Extremity, Tearfulness
This depression problem was reported by a consumer or non-health professional from UNITED STATES. A 38-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): contraception,ovarian cyst ruptured.On Nov 20, 2007 a consumer started treatment with Mononessa 28s Watson (dosage: 28s Daily Po). The following drugs/medications were being taken at the same time: NA. When commencing Mononessa 28s Watson, the patient experienced the following unwanted symptoms /side effects:
  • Depression
  • Dizziness
  • Emotional Disorder
  • Fatigue
  • Feeling Abnormal
  • Headache
  • Irritability
  • Pain In Extremity
  • Tearfulness
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as depression, may become evident only after a product is in use by the general population.

Chest Pain, Deep Vein Thrombosis, Depression, Glossodynia, Heart Rate Increased, Influenza, Irritability, Patella Fracture, Phlebitis
This is a Mononessa side effect report of a female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: contraception and was treated with Mononessa (dosage: Ethinyl Estradiol 0.035mg/ Norgestimate 0.25 Mg) starting NS. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Chest Pain
  • Deep Vein Thrombosis
  • Depression
  • Glossodynia
  • Heart Rate Increased
  • Influenza
  • Irritability
  • Patella Fracture
  • Phlebitis
The patient was hospitalized. This opens a possibility that Mononessa could cause chest pain and that some female patients may be more susceptible.

Deep Vein Thrombosis, Depression, Irritability, Patella Fracture, Phlebitis, Pleural Effusion, Pneumonia, Rhinitis Allergic, Sleep Disorder
A female patient (weight: NA) from UNITED STATES with the following symptoms: contraception started Mononessa treatment (dosage: Ethinyl Estradiol 0.035mg/ Norgestimate 0.25 Mg) on NS. Soon after starting Mononessa treatment, the consumer experienced several side effects, including:
  • Deep Vein Thrombosis
  • Depression
  • Irritability
  • Patella Fracture
  • Phlebitis
  • Pleural Effusion
  • Pneumonia
  • Rhinitis Allergic
  • Sleep Disorder
. Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Mononessa side effects, such as deep vein thrombosis.

Deep Vein Thrombosis, Patella Fracture, Pneumonia
This deep vein thrombosis side effect was reported by a physician from UNITED STATES. A female patient (weight:NA) experienced the following symptoms/conditions: contraception.The patient was prescribed Mononessa (dosage: Ethinyl Estradiol 0.035mg/ Norgestimate 0.25 Mg), which was started on NS. Concurrently used drugs: NA..When starting to take Mononessa the consumer reported symptoms, such as:
  • Deep Vein Thrombosis
  • Patella Fracture
  • Pneumonia
These side effects may potentially be related to Mononessa. The patient was hospitalized.

Headache, Intracranial Venous Sinus Thrombosis, Nausea, Neck Pain, Vomiting
This is a report of a 15-year-old female patient (weight: NA) from UNITED STATES, suffering from the following symptoms/conditions: contraception, who was treated with Mononessa 0.25 Mg Watson Laboratories (dosage: 1 Pill -0.25 Mg- Daily Po, start time: Nov 01, 2007), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Headache
  • Intracranial Venous Sinus Thrombosis
  • Nausea
  • Neck Pain
  • Vomiting
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Mononessa 0.25 Mg Watson Laboratories treatment in female patients, resulting in headache side effect.

Patella Fracture, Pneumonia, Thrombosis
This report suggests a potential Mononessa Patella Fracture, Pneumonia, Thrombosis side effect(s) that can have serious consequences. A female patient (weight: NA) from UNITED STATES was diagnosed with the following symptoms/conditions: contraception and used Mononessa (dosage: Ethinyl Estradiol 0.035mg/ Norgestimate 0.25 Mg) starting NS. Soon after starting Mononessa the patient began experiencing various side effects, including:
  • Patella Fracture
  • Pneumonia
  • Thrombosis
Drugs used concurrently: NA.The patient was hospitalized. Although Mononessa demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as patella fracture, may still occur.

Patella Fracture, Thrombosis
This Patella Fracture, Thrombosis problem was reported by a physician from UNITED STATES. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: contraception,thrombosis. On NS this consumer started treatment with Mononessa (dosage: Ethinyl Estradiol 0.035mg/ Norgestimate 0.25 Mg). The following drugs were being taken at the same time:
  • Warfarin Sodium (Even Day 5 Mg And On Odd Days 7.5mg)
When commencing Mononessa, the patient experienced the following unwanted symptoms/side effects:
  • Patella Fracture
  • Thrombosis
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as patella fracture, may become evident only after a product is in use by the general population.

Asthma, Panic Attack
This is a report of a 19-year-old female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: NA and was treated with Mononessa (dosage: NA) starting Dec 01, 2005. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Asthma
  • Panic Attack
This opens a possibility that Mononessa treatment could cause the above reactions, including asthma, and some female subjects may be more susceptible.



Top 10 Mononessa Side Effects for Men

Men Side EffectsReports

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Mononessa Side Effects

    Did You Have a Mononessa Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Mononessa for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Mononessa Safety Alerts, Active Ingredients, Usage Information

    NDC52544-247
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameMonoNessa
    Namenorgestimate and ethinyl estradiol
    Dosage FormKIT
    Route
    On market since20030101
    LabelerWatson Pharmaceuticals
    Active Ingredient(s)
    Strength(s)
    Unit(s)
    Pharma Class

    More About Mononessa

    Side Effects reported to FDA: 24

    Mononessa safety alerts: No

    Reported hospitalizations: 9

    Latest Mononessa clinical trials